Of note, DCLK1 was found also to have independent favorable prognostic impact on DFS of IBC-NED (HR=0.288, p = 0.011, 95%CI= 0.111-0.748) after adjustment of grade, age, tumor size, LVI, pN stage, HER2, Ki67, PR and neuroendocrine markers expression (Supplementary Table S4). The gene discussed is DCLK1; the disease is neoplasm.